Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
Journal of the National Cancer Institute
|
October 4, 1989
Amelioration of chemotherapy-induced thrombocytopenia by GM-CSF: apparent dose and schedule dependency
J H Edmonson, H J Long, J A Jeffries, et al.
Neurosurgery
|
January 23, 1999
Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas
S V Rajkumar, J C Buckner, P J Schomberg, et al.
American Journal of Clinical Oncology
|
February 1, 1991
5-Fluorouracil plus leucovorin in women with metastatic breast cancer. A phase II study
C L Loprinzi, J N Ingle, D J Schaid, et al.
Journal of the National Cancer Institute
|
April 20, 1988
Phase II evaluation of carboplatin in advanced endometrial carcinoma
H J Long, D M Pfeifle, H S Wieand, et al.
American Journal of Public Health
|
February 1, 1997
Homelessness in female-headed families: childhood and adult risk and protective factors
E L Bassuk, J C Buckner, L F Weinreb, et al.
Cancer
|
December 1, 1991
Does histologic grade in soft tissue sarcoma influence response rate to systemic chemotherapy?
C M van Haelst-Pisani, J C Buckner, H M Reiman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma
B V Taylor, J C Buckner, T L Cascino, et al.
Journal of Cancer and Clinical Oncology
|
July 11, 2017
QOL and Survival Comparisons by Race in Oncology Clinical Trials
A D Tan, P J Novotny, J S Kaur, et al.
Journal of Neurosurgery
|
August 10, 2000
Efficacy of neuroradiological imaging, neurological examination, and symptom status in follow-up assessment of patients with high-grade gliomas
E Galanis, J C Buckner, P Novotny, et al.
American Journal of Clinical Oncology
|
August 1, 1994
Phase I trial of combined recombinant interleukin-2 with levamisole in patients with advanced malignant disease
T G Call, E T Creagan, S Frytak, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
Journal of the National Cancer Institute
|
October 4, 1989
Amelioration of chemotherapy-induced thrombocytopenia by GM-CSF: apparent dose and schedule dependency
J H Edmonson, H J Long, J A Jeffries, et al.
Neurosurgery
|
January 23, 1999
Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas
S V Rajkumar, J C Buckner, P J Schomberg, et al.
American Journal of Clinical Oncology
|
February 1, 1991
5-Fluorouracil plus leucovorin in women with metastatic breast cancer. A phase II study
C L Loprinzi, J N Ingle, D J Schaid, et al.
Journal of the National Cancer Institute
|
April 20, 1988
Phase II evaluation of carboplatin in advanced endometrial carcinoma
H J Long, D M Pfeifle, H S Wieand, et al.
American Journal of Public Health
|
February 1, 1997
Homelessness in female-headed families: childhood and adult risk and protective factors
E L Bassuk, J C Buckner, L F Weinreb, et al.
Cancer
|
December 1, 1991
Does histologic grade in soft tissue sarcoma influence response rate to systemic chemotherapy?
C M van Haelst-Pisani, J C Buckner, H M Reiman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma
B V Taylor, J C Buckner, T L Cascino, et al.
Journal of Cancer and Clinical Oncology
|
July 11, 2017
QOL and Survival Comparisons by Race in Oncology Clinical Trials
A D Tan, P J Novotny, J S Kaur, et al.
Journal of Neurosurgery
|
August 10, 2000
Efficacy of neuroradiological imaging, neurological examination, and symptom status in follow-up assessment of patients with high-grade gliomas
E Galanis, J C Buckner, P Novotny, et al.
American Journal of Clinical Oncology
|
August 1, 1994
Phase I trial of combined recombinant interleukin-2 with levamisole in patients with advanced malignant disease
T G Call, E T Creagan, S Frytak, et al.
Page
of 8